ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541)
HK$ 14.48 -0.08 (-0.55%) Market Cap: 5.42 Bil Enterprise Value: 4.84 Bil PE Ratio: 0 PB Ratio: 6.61 GF Score: 18/100

ImmuneOnco Biopharmaceuticals (Shanghai) Inc (HKSE:01541) Transcripts

    • 1